Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds NeuroMetrix Granted European Patent Titled ‘SMART ELECTRODE ASSEMBLY FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)’

Legal
News

NeuroMetrix Granted European Patent Titled ‘SMART ELECTRODE ASSEMBLY FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)’

https://data.epo.org/publication-server/pdf-document?pn=3558446&ki=B1&cc=EP

byBenzinga Newsdesk

August 3, 2022

1 minute read

https://data.epo.org/publication-server/pdf-document?pn=3558446&ki=B1&cc=EP

Maxim Group Maintains Buy on Beam Glb, Lowers Price Target to $40

By Benzinga Newsdesk

August 15, 9:00 AM

Maxim Group analyst Tate Sullivan maintains Beam Glb (NASDAQ:BEEM) with a Buy and lowers the price target from $50 to $40.

BEEM

EPD Misses Q2 Earnings Estimates As Natural Gas Liquids Prices Decline 48%

By Lekha Gupta

August 1, 8:10 AM

Enterprise Products Partners L.P. (NYSE: EPD) reported Q2 2023 sales of $10.65 billion, missing

EPD

Arcutis Biotherapeutics Stock Climbs After Blockbuster Q1 Results

By Erica Kollmann

May 14, 5:11 PM

Arcutis Biotherapeutics reports its first-quarter financial results after the bell Tuesday.

ARQT

Events
News

‘Taylor Swift Adds 2024 U.S. Shows To Eras Tour’ – The Hollywood Reporter

By Happy Mohamed

August 3, 11:19 AM

https://www.hollywoodreporter.com/news/music-news/taylor-swift-eras-tour-more-us-concerts-1235550229/ Taylor Swift’s Eras era will last for at least another year. The superstar singer-songwriter had been set to

LYV

NeuroMetrix Granted European Patent Titled ‘SMART ELECTRODE ASSEMBLY FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)’

Related Posts

Maxim Group Maintains Buy on Beam Glb, Lowers Price Target to $40

EPD Misses Q2 Earnings Estimates As Natural Gas Liquids Prices Decline 48%

Arcutis Biotherapeutics Stock Climbs After Blockbuster Q1 Results

‘Taylor Swift Adds 2024 U.S. Shows To Eras Tour’ – The Hollywood Reporter